Lunit joins as an Associate Partner of the World Economic Forum, propelling global expansion and collaboration in the realm of AI-driven cancer care
Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has expanded its collaboration with the World Economic Forum by joining as an Associate Partner of the forum.
This achievement marks one of the first instances in Asia and among medical AI companies worldwide, where a company has progressively elevated its collaboration with the forum from its initial status as a Technology Pioneer to an Associate Partner.
Recommended AI News: New Cisco Technology Can Predict Network Issues Before They Happen
Lunit’s journey with the forum began in 2020 when it joined as a member of the Technology Pioneer community, earning recognition as one of the 100 leading global tech companies—the sole Korean company on the prestigious list of the year.
Building upon this foundation, in 2022, Lunit solidified its position as a key player in the global AI-driven healthcare landscape by becoming a member of the forum’s Unicorn community. In this capacity, Lunit shared insights into the future of AI-driven global healthcare during the forum’s events, including annual meetings in Davos, Switzerland and in Tianjin, China.
“As a global platform, the Forum is thrilled to welcome companies like Lunit in their mission to combat cancer through AI and promote the best possible healthcare, contributing to the well-being of individuals in societies and nations,” said Dr. Shyam Bishen, Head of the Centre for Health & Healthcare at the World Economic Forum.
Recommended AI News: Cyient to Acquire Portugal-Based Celfinet to Strengthen its Wireless Communications Offerings
“The partnership extension, especially the unique access to a global platform at the highest level at forum meetings, strongly supports our commitment to advancing the landscape of the entire cycle of cancer care through AI-driven solutions,” said Brandon Suh, CEO of Lunit. “We are excited to harness the network to accelerate our expansion, make significant strides in combating one of the most formidable global health challenges – cancer -, and addressing inequities in healthcare access.”
Lunit’s dedication to forming global alliances aligns with its mission to combat cancer through AI solutions for precision diagnostics and treatment support. The flagship Lunit INSIGHT suite for early detection of chest and breast cancer is now operational in approximately 2,500+ hospitals and medical institutions across 40+ countries, marking significant progress in advancing the field of medical AI.
Recommended AI News: Getty Images Revolutionizes Visual Communications with VisualGPS Insights Launch
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.